stella
beta
Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer — Stella
Recruiting
Back to Early Stage Non-Small Cell Lung Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
University of Pennsylvania, Philadelphia, Pennsylvania
View full record on ClinicalTrials.gov